Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Rafferty

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
International Journal of Health Care Quality Assurance|June 4, 2016
An improvement model to optimise hospital interdisciplinary learningDeborah A McNamara, Paul Rafferty, Fidelma Fitzpatrick
BMJ Open Quality|October 10, 2022
Development, implementation and evaluation of high-quality virtual preoperative anaesthetic assessment during COVID-19 and beyond: a quality improvement reportPetar Popivanov, Sohail Bampoe, Terry Tan, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Pyrrolo[2,3-d]pyrimidines containing diverse N-7 substituents as potent inhibitors of LckDavid J Calderwood, David N Johnston, Rainer Munschauer, et al.
BMC Health Services Research|October 1, 2025
Use of implementation science frameworks to identify core components and sustainability characteristics of a quality improvement learning collaborativeDeborah A McNamara, Peter E Lonergan, Paul Rafferty, et al.
European Journal of Hospital Pharmacy : Science and Practice|November 7, 2022
Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendationsKevin J Frost, Ryan A Hamilton, Stephen Hughes, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Pyrazolo[3,4-d]pyrimidines containing an extended 3-substituent as potent inhibitors of Lck -- a selectivity insightAndrew F Burchat, David J Calderwood, Michael M Friedman, et al.
International Journal of STD & AIDS|April 21, 2016
UK guideline for the use of HIV Post-Exposure Prophylaxis Following Sexual Exposure, 2015Fiona Cresswell, Laura Waters, Eleanor Briggs, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2008
Synthesis and in vitro activity of N'-cyano-4-(2-phenylacetyl)-N-o-tolylpiperazine-1-carboximidamide P2X7 antagonistsMichael J Morytko, Patrick Betschmann, Kevin Woller, et al.
HIV Medicine|February 15, 2022
UK guideline for the use of HIV post-exposure prophylaxis 2021Fiona Cresswell, Kaveh Asanati, Sanjay Bhagani, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2008
Synthesis and activity of N-cyanoguanidine-piperazine P2X7 antagonistsPatrick Betschmann, Brian Bettencourt, Diana Donnelly-Roberts, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
International Journal of Health Care Quality Assurance|June 4, 2016
An improvement model to optimise hospital interdisciplinary learningDeborah A McNamara, Paul Rafferty, Fidelma Fitzpatrick
BMJ Open Quality|October 10, 2022
Development, implementation and evaluation of high-quality virtual preoperative anaesthetic assessment during COVID-19 and beyond: a quality improvement reportPetar Popivanov, Sohail Bampoe, Terry Tan, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Pyrrolo[2,3-d]pyrimidines containing diverse N-7 substituents as potent inhibitors of LckDavid J Calderwood, David N Johnston, Rainer Munschauer, et al.
BMC Health Services Research|October 1, 2025
Use of implementation science frameworks to identify core components and sustainability characteristics of a quality improvement learning collaborativeDeborah A McNamara, Peter E Lonergan, Paul Rafferty, et al.
European Journal of Hospital Pharmacy : Science and Practice|November 7, 2022
Systematic review of high-dose amikacin regimens for the treatment of Gram-negative infections based on EUCAST dosing recommendationsKevin J Frost, Ryan A Hamilton, Stephen Hughes, et al.
Bioorganic & Medicinal Chemistry Letters|June 1, 2002
Pyrazolo[3,4-d]pyrimidines containing an extended 3-substituent as potent inhibitors of Lck -- a selectivity insightAndrew F Burchat, David J Calderwood, Michael M Friedman, et al.
International Journal of STD & AIDS|April 21, 2016
UK guideline for the use of HIV Post-Exposure Prophylaxis Following Sexual Exposure, 2015Fiona Cresswell, Laura Waters, Eleanor Briggs, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2008
Synthesis and in vitro activity of N'-cyano-4-(2-phenylacetyl)-N-o-tolylpiperazine-1-carboximidamide P2X7 antagonistsMichael J Morytko, Patrick Betschmann, Kevin Woller, et al.
HIV Medicine|February 15, 2022
UK guideline for the use of HIV post-exposure prophylaxis 2021Fiona Cresswell, Kaveh Asanati, Sanjay Bhagani, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2008
Synthesis and activity of N-cyanoguanidine-piperazine P2X7 antagonistsPatrick Betschmann, Brian Bettencourt, Diana Donnelly-Roberts, et al.
Pageof 2